Anavex Life Sciences Corp.AVXLNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P95
Near historical high
vs 2Y Ago
3.7x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 37.46% |
| Q3 2025 | 25.00% |
| Q2 2025 | -15.55% |
| Q1 2025 | 7.94% |
| Q4 2024 | 5.19% |
| Q3 2024 | 1.83% |
| Q2 2024 | -15.68% |
| Q1 2024 | -10.95% |
| Q4 2023 | 10.07% |
| Q3 2023 | 6.49% |
| Q2 2023 | 4.64% |
| Q1 2023 | 7.61% |
| Q4 2022 | -0.49% |
| Q3 2022 | -22.68% |
| Q2 2022 | -8.15% |
| Q1 2022 | 1.74% |
| Q4 2021 | 4.31% |
| Q3 2021 | -7.89% |
| Q2 2021 | -26.96% |
| Q1 2021 | 4.81% |
| Q4 2020 | -25.15% |
| Q3 2020 | 7.38% |
| Q2 2020 | -5.30% |
| Q1 2020 | -0.95% |
| Q4 2019 | -21.60% |
| Q3 2019 | 11.33% |
| Q2 2019 | 12.32% |
| Q1 2019 | -9.01% |
| Q4 2018 | -27.25% |
| Q3 2018 | -27.97% |
| Q2 2018 | 4.03% |
| Q1 2018 | -15.70% |
| Q4 2017 | 20.97% |
| Q3 2017 | -42.39% |
| Q2 2017 | -1.22% |
| Q1 2017 | -14.64% |
| Q4 2016 | 52.20% |
| Q3 2016 | -191.88% |
| Q2 2016 | -4.30% |
| Q1 2016 | 45.10% |